Alexion Pharmaceuticals and Syntimmune have entered into a definitive agreement for Alexion to acquire Syntimmune, a cli...
Anaeropharma Science Inc. headquartered in Tokyo (hereafter "Anaeropharma") has announced that Anaeropharma and Ast...
Accenture and Merck, known as MSD outside the United States and Canada, in collaboration with Amazon Web Services (AWS),...
Singapore - Pfizer announced its investigational oral Janus kinase 3 (JAK3) inhibitor PF-06651600 received Breakthr...
China-based Chi-Med has announced that fruquintinib capsules have been granted approval for drug registration by the Nat...
China's commercial-stage biopharmaceutical company BeiGene, recently announced the acceptance by the Ch...
Singapore- The U.S. Food and Drug Administration approved the first drug, Oxervate (cenegermin), for the treatment of ne...
India's Strides Pharma has announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limite...
Edmonton's General Intermediates of Canada Inc. (GIC) has received conditional funding from the National Research Counci...
Roche recently announced that the China National Drug Administration (CNDA) has granted marketing authorization fo...
HitGen Ltd has announced a multi-year major drug discovery research collaboration with LG Chem to identify novel small m...
Blueberry Therapeutics Limited, a drug discovery and development company focused on developing innovative nanomedicines ...
The Buck Institute, Juvenescence, and Insilico Medicine have announced a research collaboration utilizing artificial int...
Singapore – The U.S. Food and Drug Administration recently approved Galafold (migalastat), the first oral medicati...
Pfizer China announced that the China National Drug Administration (CNDA) has granted approval of IBRANCE® (palbocic...
Singapore – DotBio, a new company focused on the development of novel immuno-oncology drugs based on humanize...
MedPacto, that announced today a clinical collaboration with AstraZeneca to evaluate the safety and efficacy of MedPacto...
Singapore – The European Commission approves Pfizer's TRAZIMERA, a biosimilar of Roche's cance...
